Mansuo L. Hayashi

Publications

708

Citations

H-Index

2004

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Eli Lilly (United States)

Massachusetts Institute of Technology

National Centre for Biological Sciences

Tata Institute of Fundamental Research

Mansuo L. Hayashi is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, signal transduction, and natural sciences.

Top concepts

MedicineCell BiologyPharmacologyNatural SciencesSignal TransductionBiochemistryCytoskeletonNeuroscienceCell SignalingDrug Discovery

Publications per year

2004–2022

Publications

Inhibition of p21-activated kinase rescues symptoms of fragile X syndrome in mice

Mansuo L. Hayashi, B.S. Shankaranarayana Rao, Jinsoo Seo et al. · Proceedings of the National Academy of Sciences · 2007 · 271 citations · Full text

Fmr1 Ko Mice, Genetics, Social Sciences +20

Altered Cortical Synaptic Morphology and Impaired Memory Consolidation in Forebrain- Specific Dominant-Negative PAK Transgenic Mice

Mansuo L. Hayashi, Se‐Young Choi, B.S. Shankaranarayana Rao et al. · Neuron · 2004 · 270 citations · Full text

Synaptic Plasticity, Molecular Neuroscience, Neuroanatomy +12

Glucose Regulates Microtubule Disassembly and the Dose of Insulin Secretion via Tau Phosphorylation

Kung‐Hsien Ho, Xiaodun Yang, Anna B. Osipovich et al. · Diabetes · 2020 · 55 citations · Full text

Protein Secretion, Cytoskeleton, Microtubule Turnover +20

[O2–14–05]: PRECLINICAL CHARACTERIZATION OF AN ANTIBODY [LY3303560] TARGETING AGGREGATED TAU

Riazul Alam, David A. Driver, Su Wu et al. · Alzheimer s & Dementia · 2017 · 42 citations

Immunocytochemical Technique, Laboratory Immunology, Soluble Tau Aggregate +16

Identification of Direct Target Engagement Biomarkers for Kinase-Targeted Therapeutics

Cloud P. Paweletz, Jannik N. Andersen, Roy M. Pollock et al. · PLoS ONE · 2011 · 29 citations · Full text

Rows per page

1–5 of 8